|
Arotech Warrant Issuance
Receives Overwhelming Approval From Stockholders
December
14, 2004 - Arotech Corporation (NasdaqNM: ARTX) announced today
that a special stockholders meeting that was held this morning ,
approved a proposal to ratify, for purposes of NASD Marketplace
Rule 4350(i)(1)(C)(ii), the issuance in July 2004 of five-year warrants
to purchase up to 8,717,265 shares of Arotech’s common stock.
The resolution ratifying the warrant
issuance received the support of approximately 78% of the votes
cast in person and by proxy on the proposal.
“We greatly appreciate that
our growth objectives have received this strong show of support
from our stockholders,” said Robert S. Ehrlich, Chairman and
CEO of Arotech. “We have taken a series of successful strategic
steps over the past few years, including the acquisition of several
excellent companies, to transform Arotech into a major vendor of
security and defense equipment. It is gratifying to see the extent
to which our shareholders support these steps.”
About Arotech Corporation
Arotech Corporation provides quality
defense and security products for the military, law enforcement
and homeland security markets, including advanced zinc-air and lithium
batteries and chargers, multimedia interactive simulators/trainers
and lightweight armoring.
The Battery and Power Systems Division
includes Electric Fuel Battery Corporation and Epsilor Electronic
Industries Ltd. The Simulation and Training Division includes IES
Interactive Training and FAAC Incorporated. The Armoring Division
includes MDT Armor Corp., MDT Protective Industries Ltd. and Armour
of America, Incorporated.
Arotech is incorporated in Delaware,
with corporate offices in New York, and research, development and
production subsidiaries in Alabama, Colorado, Michigan, California
and Israel.
Except for the historical information herein,
the matters discussed in this news release include forward-looking
statements, as defined in the Private Securities Litigation Reform
Act of 1995. Readers are cautioned not to place undue reliance on
these forward-looking statements, as they are subject to various
risks and uncertainties that may cause actual results to vary significantly.
These risks and uncertainties include, but are not limited to, risks
relating to: product and technology development; the uncertainty
of the market for Arotech’s products; changing economic conditions;
delay, cancellation or non-renewal, in whole or in part, of contracts
or of purchase orders; and other risk factors detailed in Arotech’s
most recent Annual Report on Form 10-K for the fiscal year ended
December 31, 2003, as amended, and other filings with the Securities
and Exchange Commission. Arotech assumes no obligation to update
the information in this release. Reference to the Company’s
website above does not constitute incorporation of any of the information
thereon into this press release.
|